Infectious Diseases

Comprehend Systems Appoints New CEO in Response to Surging Demand for Clinical Intelligence Solutions; Enterprise Growth Expert to Scale Company and Expand Partner Ecosystem

November 20, 2017

Redwood City, Calif., November 13, 2017—Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, has named Terry Cunningham CEO.  Cunningham will focus on scaling Comprehend in response to explosive customer demand for solutions that reduce time and risk in clinical trials. Cunningham will also drive expanded partner programs to help sponsors achieve faster, better clinical […]

HHS, Regeneron partner on portfolio of treatments for emerging diseases

October 3, 2017

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron Pharmaceuticals, Inc. of Tarrytown, New York, will forge a public-private partnership to drive development of an entire portfolio of products to treat influenza and other emerging infectious diseases. The Biomedical Advanced Research and Development Authority […]

HHS spurs new antibiotic development for biodefense and common infections

September 11, 2017

To combat potentially deadly Clostridium difficile infections that can occur in patients being treated for bacterial infections including anthrax, tularemia and other biothreats, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is partnering with Summit Therapeutics on late-stage development of a new antibiotic. “To save […]

New Certara Paper Shows How Viral Kinetic Modeling Increases Influenza Knowledge and Advances Drug Development

September 7, 2017

Paper highlights benefits of combining different types of mathematical modeling to maximize use of all available pre-clinical, clinical and epidemiological data Certara®, the global leader in model-informed drug development and regulatory science, today announced that its comprehensive influenza viral kinetic modeling review has just been published in Current Pharmacology Reports. As the number of drug-resistant […]

FEEDBACK